TGFB1 and colitis: Exosomes secreted by BMDC genetically modified to express the gene encoding TGF-β1 (TGF-β/BMDC) were able to increase Treg cells and suppress Th17 response in DSS-treated mice, thus protecting against experimental colitis [100].